178 related articles for article (PubMed ID: 35562598)
21. [Vascular targeted photodynamic therapy in low-risk prostate cancer. A literature review].
Kleinclauss F; Frontczak A; Balssa L; Lebdai S; Azzouzi R
Prog Urol; 2019; 29(8-9):393-401. PubMed ID: 31266699
[TBL] [Abstract][Full Text] [Related]
22. Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy.
Moore CM; Azzouzi AR; Barret E; Villers A; Muir GH; Barber NJ; Bott S; Trachtenberg J; Arumainayagam N; Gaillac B; Allen C; Schertz A; Emberton M
BJU Int; 2015 Dec; 116(6):888-96. PubMed ID: 24841929
[TBL] [Abstract][Full Text] [Related]
23. Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® Soluble focal treatment for localized prostate cancer.
Lebdai S; Villers A; Barret E; Nedelcu C; Bigot P; Azzouzi AR
World J Urol; 2015 Jul; 33(7):965-71. PubMed ID: 25614256
[TBL] [Abstract][Full Text] [Related]
24. Decision Regret and Quality of Life after Focal Therapy with Vascular-Targeted Photodynamic Therapy (TOOKAD®) for Localized Prostate Cancer.
Flegar L; Baunacke M; Buerk BT; Proschmann R; Zacharis A; Propping S; Huber J; Thomas C; Borkowetz A
Urol Int; 2022; 106(9):903-908. PubMed ID: 34814157
[TBL] [Abstract][Full Text] [Related]
25. Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center.
Sivaraman A; Marra G; Stabile A; Mombet A; Macek P; Lanz C; Cathala N; Moschini M; Carneiro A; Sanchez-Salas R; Cathelineau X
Int Braz J Urol; 2020; 46(6):984-992. PubMed ID: 32822127
[TBL] [Abstract][Full Text] [Related]
26. Target ablation--image-guided therapy in prostate cancer.
Marien A; Gill I; Ukimura O; Betrouni N; Villers A
Urol Oncol; 2014 Aug; 32(6):912-23. PubMed ID: 24411788
[TBL] [Abstract][Full Text] [Related]
27. Fiducial markers and their impact on ablation outcome for patients treated with MR-guided transurethral ablation (TULSA): a retrospective technical analysis.
Wright C; Mäkelä P; Anttinen M; Sainio T; Boström PJ; Blanco Sequeiros R
Int J Hyperthermia; 2021; 38(1):1677-1684. PubMed ID: 34927517
[TBL] [Abstract][Full Text] [Related]
28. Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer.
Mäkelä P; Anttinen M; Suomi V; Steiner A; Saunavaara J; Sainio T; Horte A; Taimen P; Boström P; Blanco Sequeiros R
Acta Radiol; 2021 Dec; 62(12):1687-1695. PubMed ID: 33251811
[TBL] [Abstract][Full Text] [Related]
29. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
[TBL] [Abstract][Full Text] [Related]
30. Erectile function after focal therapy for localized prostate cancer: a systematic review.
Fallara G; Capogrosso P; Maggio P; Taborelli A; Montorsi F; Dehò F; Salonia A
Int J Impot Res; 2021 May; 33(4):418-427. PubMed ID: 32999435
[TBL] [Abstract][Full Text] [Related]
31. High-intensity focused ultrasound as focal therapy of prostate cancer.
Crouzet S; Rouviere O; Martin X; Gelet A
Curr Opin Urol; 2014 May; 24(3):225-30. PubMed ID: 24710053
[TBL] [Abstract][Full Text] [Related]
32. Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure.
Azzouzi AR; Lebdai S; Benzaghou F; Stief C
World J Urol; 2015 Jul; 33(7):937-44. PubMed ID: 25786708
[TBL] [Abstract][Full Text] [Related]
33. An Exploratory Study of Dose Escalation
Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
[No Abstract] [Full Text] [Related]
34. High-intensity focused ultrasound strategies for treating prostate cancer.
Wu X; Wu Y; Ng CF; Yee CH; Chiu PK
Asian J Androl; 2024 Apr; ():. PubMed ID: 38727256
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
[TBL] [Abstract][Full Text] [Related]
36. [Clinical, morphological and microcirculatory criteria of local recurrence of the prostate cancer after HIFU therapy].
Neymark AI; Tachalov MA; Neymark BA; Levin VP
Urologiia; 2020 Jun; (3):69-76. PubMed ID: 32597589
[TBL] [Abstract][Full Text] [Related]
37. Focal High-intensity Focussed Ultrasound Partial Gland Ablation for the Treatment of Localised Prostate Cancer: A Report of Medium-term Outcomes From a Single-center in the United Kingdom.
Johnston MJ; Emara A; Noureldin M; Bott S; Hindley RG
Urology; 2019 Nov; 133():175-181. PubMed ID: 31449831
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of localized prostate cancer with high-intensity focused ultrasound].
Baumunk D; Schostak M
Urologe A; 2015 Feb; 54(2):183-90. PubMed ID: 25588324
[TBL] [Abstract][Full Text] [Related]
39. Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques.
Anttinen M; Blanco Sequeiros R; Boström PJ; Taimen P
Front Oncol; 2022; 12():1043688. PubMed ID: 36465377
[TBL] [Abstract][Full Text] [Related]
40. Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad.
Madar-Balakirski N; Tempel-Brami C; Kalchenko V; Brenner O; Varon D; Scherz A; Salomon Y
PLoS One; 2010 Apr; 5(4):e10282. PubMed ID: 20421983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
